BIRC5 and renal cell carcinoma: To obtain a more precise evaluation of the prognostic and clinicopathological value of survivin expression in RCC, we conducted a systematic review and meta-analysis to evaluate the prognostic value of survivin quantitatively and explore the associations of survivin with the clinicopathological features of RCC.